Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
Go back to Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer| Merck & Co. (NYSE: MRK) | Delayed: 135.97 +0.13 (0.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.84 | 52 Week High | $65.46 | |||
| Open | $134.95 | 52 Week Low | $47.97 | |||
| Day High | $137.17 | P/E | 92.50 | |||
| Day Low | $134.55 | EPS | $1.47 | |||
| Volume | 8,457,729 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 805.93 +2.45 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $803.48 | 52 Week High | $592.36 | |||
| Open | $801.76 | 52 Week Low | $325.35 | |||
| Day High | $813.18 | P/E | 211.53 | |||
| Day Low | $795.73 | EPS | $3.81 | |||
| Volume | 541,283 | |||||
